COMP <GO>
IREN vs BRK-A // 10Y YIELD & FRED MACRO BETA
IREN Limited (NASDAQ) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: IREN 2
— BRK-A 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: BRK-A
LAST: $23.95 (-8.76%) • MKT CAP: $10.62B
macro-sensitivity
1.08
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
macro-sensitivity
1.13
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 11.47% | -10.27 | BRK-A | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 9.7x | +8.62 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | 2.09% | -5.17 | BRK-A | /fcf-yield <GO> |
| Operating Margin | 3.50% | 27.80% | -24.30 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 22.30% | -4.90 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 3.93% | +163.77 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 68.1 | -30.80 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 1.13 | -0.05 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 24.3x | +78.26 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $1.20T | -$1.19T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | BRK-A REV | IREN GROSS % | BRK-A GROSS % | IREN FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $247.24B | 68.3% | — | -$327.6M | $25.04B |
| FY 2024 | $187.2M | $249.71B | 53.5% | — | -$89.6M | $11.62B |
| FY 2023 | $75.5M | $254.91B | — | — | $2.3M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
BRK-A // BETA 1.13